维普中文期刊产品整合服务
65篇 您的检索式:作者名="Hissa"
    题名 作者 年代 出处 被引量
1The efficacy and safetyof saxagliptin when added to metformin therapy in patients withinadequately controlled type 2 diabetes with metformin alone显示文摘DeFronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,:1
2Event related P300potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes显示文摘Hissa MN D'Almeida JA Cremasco F 2002Neuroendocrinol Lett2002,23,:1
3The efficacy and safety of saxagliptin when add on to mefformin therapy in patients with inadequately controlled type 2 diabetes with mefformin alone 显示文摘DeFronzo RA Hissa MN Garb AJ 2009Diabetes Care2009,32,9:1
4Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous mypoglycemic episocles显示文摘Hissa MN D' Almeida JA Cremasco F 2002Neuroendoctinot Lett2002,23,3:1
5The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with met- formin alone显示文摘DeFronzo R A Hissa M N Garber A J 2009Diabetes Care2009,32,9:1
6The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes on metformin alone 显示文摘DeFronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,9:1
7The efficacy andsafety of saxagliptin when added to metformin therapy inpatients with inadequately controlled type 2 diabetes withmetformin alone显示文摘Defronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,9:1
8Bovine muscle glycogen concentration in relation to finishing diet,slaughter and ultimate pH显示文摘Immonen K Ruusunen M Hissa K 2000Meat Sci2000,55,:1
9The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone显示文摘DeFronzo RA Hissa MN Garber AJ 0,,09:1
10Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes显示文摘Hissa MN D′Almeida JA Cremasco F 2002Neuroendocrinol Lett2002,23,11:1
11The efficacy and safetyof saxagliptin when added to metformin therapy in patients withinadequately controlled type 2 diabetes with metformin alone显示文摘DeFronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,9:1
12The effect of cell wall degrading enzymes or formic acid on fer- mentation quality and on digestion of grass silage by cattle显示文摘JAAKKOLA S HUHTANEN P HISSA K 1991Grass and Forage Science1991,46,1:1
13Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes 显示文摘Hissa MN D'Almeida JA Cremasco F 2002Neuroendocrinol Lett2002,23,3:1
14The efficacy andsafety of saxagliptin when added to metformin therapy in patientswith inadequately controlled type 2 diabetes with metformin alone显示文摘DeFronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,9:1
15The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadeq- uately controlled type 2 diabetes with metformin alone 显示文摘DeFronzo RA Hissa MN Garber A J 2009Diabetes Care2009,32,9:1
16Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes显示文摘 D' Almeida JA Cremasco F 2002Neuro Endocrinoi Lett2002,23,:1
17The efficacy and safety of saxagliptin when added to rnetformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone显示文摘DeFronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,9:1
18The efficacy and safety of saxzgliptin when added to metformin therapy in patients with inadeq- uately controlled type 2 diabetes with metformin alone 显示文摘DeFronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,9:1
19Bovine muscle glycogen concentration in relation to finishing diet, slaughter and ultimate pH显示文摘Immone K M Ruusunen K Hissa et 01 2000Meat Sei2000,55,1:1
20Event related P300 potential in NIDDM patients without cognitive impairment and its relationship with previous hypoglycemic episodes 显示文摘Hissa MN D'Almeida JA Cremasco F 2002Neuroendoerinol Lett2002,23,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费